naloxone
Generic: NALOXONE HYDROCHLORIDE·Brand: Bunavail, EVZIO, EVZIO (AUTOINJECTOR), KLOXXADO, Kloxxado, NALOXONE, NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (AUTOINJECTOR), NARCAN, Narcan, REXTOVY, REZENOPY, RIVIVE, Rextovy, Rezenopy, Suboxone, ZIMHI, Zimhi, Zubsolv
naloxone: developed by 1 company · 1 clinical trial tracked.
naloxone evidence translation
What we can confirm
1 tracked trial
What it means
Source-backed records connect naloxone to INSY; that link alone does not prove the drug works.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
How could naloxone → INSY affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Opioid antagonist
Study sponsors
Development Pipeline (1)
| Company | Phase |
|---|---|
| Insys Therapeutics, Inc. (INSY) Opioid antagonist | Preclinical |
Clinical Trials (1)
A Two-part Open Label Study of the Pharmacodynamic Effects of Intranasal Nalmefene Compared to Intranasal Naloxone in Healthy Volunteers Under Steady State Opioid Agonism
Primary endpoint: Change in Minute Ventilation
InterventionalRandomizedopen84 enrolledStarted 2021-03Completion 2022-031 site · United StatesOpiant Pharmaceuticals Inc
Frequently asked questions
Who is developing naloxone?
naloxone is being developed by Insys Therapeutics, Inc..
How many clinical trials involve naloxone?
BioSniper tracks 1 clinical trial involving naloxone.